Global /Taiwan /Technology /Software - Application /7829

Yoda Pharmaceuticals Inc.

7829

• TPEX: 7829 • Delayed

45.10TWD -0.4%

1.43 USD

As of 5 June 2026, Yoda Pharmaceuticals Inc. has a market cap of $113.82M USD, ranking #24662 globally and #1298 in Taiwan. It ranks #3644 in the Technology sector, and #1067 in the Software - Application industry.

Global Rank

24662

Country Rank

1298

Sector Rank

3644

Industry Rank

1067

Key Stats

Market Cap

$113.82MUSD

3.58B TWD

Enterprise Value

$103.5MUSD

3.26B TWD

EBITDA (TTM)

-$12.4MUSD

-390.21M TWD

Net Income (TTM)

-$12.95MUSD

-407.22M TWD

PB Ratio

3.6

Company Profile

Country (HQ)

Taiwan

Sector

Technology

Industry

Software - Application

CEO

Yufeng Tseng open_in_new

Founded

2019

Website

yodapharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.4%	-8%	-0.3%	-28%	-27%	-23%	14%	3.5%	3.5%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	7829 Yoda Pharmaceuticals Inc ISIN: KYG8851R1065 Shares Out.: Shares Outstanding: 99.388M¹ TV: TradingView: TPEX: 7829 SA: Stock Analysis: TPEX: 7829 YF: Yahoo Finance: 7829.TWO GF: Google Finance: TPEX: 7829 BA: Barron's: 7829 MS: Morningstar: ROCO: 7829	45.10 TWD	TV: TradingView: TPEX: 7829 SA: Stock Analysis: TPEX: 7829 YF: Yahoo Finance: 7829.TWO GF: Google Finance: TPEX: 7829 BA: Barron's: 7829 MS: Morningstar: ROCO: 7829

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Yoda Pharmaceuticals Inc.

Yoda Pharmaceuticals Inc., an AI-driven company, focuses on development of drugs targeting central nervous system disorders. The company’s flagship drug, YA-101 is in Phase 2 clinical trial for the treatment of multiple system atrophy. It is also involved in the development pipeline includes drugs in the field of neurological and psychiatric disorders and cerebrovascular diseases, targeting conditions, such as schizophrenia, Alzheimer's disease, Parkinson‘s disease, Autism, ischemic stroke, and traumatic brain injury. Yoda Pharmaceuticals Inc. was incorporated in 2019 and is based in Grand Cayman, the Cayman Islands.

Similar Companies

Industry: Software - Application (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
International Games System Co.,Ltd. TPEX: 3293	$6.77B 213.04B TWD 6K%	20.0	Taiwan
V5 Technologies Co., Ltd. TWSE: 7822	$1.9B 59.91B TWD 2K%	93.9	Taiwan
Systex Corp. TWSE: 6214	$1.05B 33.08B TWD 824%	15.4	Taiwan
AIC Inc. TPEX: 3693	$845.96M 26.61B TWD 643%	40.3	Taiwan
M31 Technology Corp. TPEX: 6643	$720.18M 22.65B TWD 533%	320.9	Taiwan
TPIsoftware Corp. TPEX: 7781	$551.53M 17.35B TWD 385%	-	Taiwan

Industry: Software - Application (Global)

Name	Market Cap (USD) diff.	PE	Country
Alphabet Inc. NASDAQ: GOOG	$4.23T 4M%	32.0	United States
Microsoft Corp. NASDAQ: MSFT	$3.15T 3M%	26.6	United States
Meta Platforms, Inc. NASDAQ: META	$1.7T 1M%	28.5	United States
Tencent Holdings Ltd. SHEK: 700	$551.68B 4.32T HKD 485K%	17.8	China
Oracle Corp. NYSE: ORCL	$471.18B 414K%	29.4	United States
Netflix, Inc. NASDAQ: NFLX	$387.9B 341K%	29.8	United States

chevron_leftBack